CREO Inc., the preferred consultancy to the world's most
promising companies that seek to improve human health, today
announced that Mike Townley,
President and Co-Founder, has been honored with the Triangle
Business Journal's 2024 Life Sciences Award.
DURHAM,
N.C., April 26, 2024 /PRNewswire-PRWeb/ -- CREO
Inc., the preferred consultancy to the world's most promising
companies that seek to improve human health, today announced that
Mike Townley, President and
Co-Founder, has been honored with the Triangle Business Journal's
2024 Life Sciences Award.
"Mike's recognition is a testament to the
hard work and dedication he brings to our firm and the life
sciences industry overall," said Susan
Acker-Walsh, CEO and Co-Founder of CREO.
This prestigious accolade recognizes Townley's contributions to
the life sciences sector, highlighting his commitment to improving
human health through innovative business strategies and
leadership.
The Triangle Business Journal (TBJ) 2024 Life Sciences Award is
an esteemed honor that celebrates outstanding leaders making
noteworthy strides in the life sciences field. Townley's receipt of
this award underscores his instrumental role at CREO and the firm's
dedication to serving life sciences, healthcare, and private equity
portfolio companies. Townley and other award recipients will be
recognized at private honoree dinner on May
16th hosted by the TBJ at the Angus Barn in Raleigh.
CREO has been serving growing companies committed to improving
human health since 2015. Townley's leadership has been pivotal in
steering CREO's mission to help organizations improve business
performance and foster clinical innovations.
"Mike's recognition is a testament to the hard work and
dedication he brings to our firm and the life sciences industry
overall," said Susan Acker-Walsh,
CEO and Co-Founder of CREO. "His expertise, unwavering commitment,
and innovative thinking have been critical to CREO's success
serving life sciences and healthcare companies."
In his role as President, Townley has been instrumental in
helping CREO clients navigate the complexities of strategy,
M&A, digital transformation, cybersecurity, IT quality and
regulatory compliance. His strategic vision and hands-on approach
have been vital in guiding CREO's clients towards continued
growth.
Townley's contributions extend beyond his role at CREO. His
commitment to improving human health has had a substantial impact
on the broader life sciences landscape. This award underscores his
ongoing efforts to advance the sector.
Acker-Walsh added, "This award is not just an acknowledgment of
Mike's individual achievements. It also shines a spotlight on the
vital work our team at CREO performs every day. We are committed to
making a meaningful difference in the world of life sciences and
healthcare."
Complete results of the TBJ Life Sciences Awards are available
in a recent article on the publication's website.
About CREO
CREO, Inc. is the preferred consultancy to the world's most
promising companies that seek to improve human health. CREO serves
growing life sciences, healthcare, and private equity portfolio
companies across the U.S. and international markets. The company's
expertise and knowledge in Strategy, M&A, Digital
Transformation, Cybersecurity, and IT Quality & Regulatory
Compliance help organizations improve today's business performance
and develop tomorrow's clinical innovations. Founded in 2015, CREO
is headquartered in North
Carolina's Research Triangle
Park. Join us and together let's make a meaningful
difference. Visit CREO at www.creoinc.net.
Media Contact
James Forte, CREO Inc., 1
919-961-4066, jforte@creoinc.net, https://www.creoinc.net
View original content to download
multimedia:https://www.prweb.com/releases/creos-mike-townley-receives-triangle-business-journals-2024-life-sciences-award-302128130.html
SOURCE CREO Inc.